← All Sponsors
SPONSOR

Drahomir Aujesky

Total Trials
1
Recruiting
1
Phases
Phase 4

Drahomir Aujesky is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases.

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Drahomir Aujesky

How many clinical trials has Drahomir Aujesky sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Drahomir Aujesky, of which 1 are actively recruiting participants. These trials cover conditions including Pulmonary Embolism, Embolism, Embolism and Thrombosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Drahomir Aujesky research focus on?
Drahomir Aujesky clinical trials span Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases, Cardiovascular Diseases, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Drahomir Aujesky clinical trial?
To participate in a Drahomir Aujesky trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Drahomir Aujesky trials with current recruitment status updated daily.

Clinical Trials by Drahomir Aujesky

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology